Reducing Depressive Symptoms in Physically Ill Youth

Depression Clinical Trial

Official title:

Reducing Depressive Symptoms in Physically Ill Youth

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00534911
• Other study ID #: 0606136
• Status: Completed
• Phase: N/A
• Start date: September 2007
• Est. completion date: December 2019

Study information

• Verified date: January 2020
• Source: University of Pittsburgh
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Children and adolescents with inflammatory bowel disease (IBD) have high rates of depressive symptoms and more trouble with daily functioning than those without physical illness. The proposed study will investigate if cognitive behavioral therapy (CBT) is better than supportive therapy (SNDT) in reducing emotional distress and improving functioning in youth ages 9-17 with Crohn's disease or Ulcerative Colitis and depression. This study will also assess the effect of CBT on IBD-related factors such as disease severity, medication adherence, and physical-health related quality of life.

Hypothesis

• Individuals who receive CBT will show more improvement than individuals who receive SNDT.

Description:

Children and adolescents with inflammatory bowel disease (IBD) have high rates of depressive symptoms and more trouble with daily functioning than those without physical illness. Furthermore, the medications used to treat IBR, such as steroids, may induce depression. The proposed study will investigate if cognitive behavioral therapy (CBT) is better than supportive therapy (SNDT) in reducing emotional distress and improving functioning in youth ages 9-17 with Crohn's disease and depression. This study will also be the first to assess the effect of CBT on IBD-related factors such as disease severity, medication adherence, and physical-health related quality of life.

Participants will be carefully evaluated for depression and those who have clinically significant depression will be randomly assigned to either CBT designed for youth with IBD or supportive therapy sessions. Youth in the CBT group will learn new ways of thinking and acting to reduce symptoms of depression focused on the reconstruction of negative or hopeless physical illness narratives. Parents in the CBT group will participate in three family sessions designed to improve family understanding and communication about the physical illness and about risks for developing depression. Children in the supportive therapy condition will receive social support and information about IBD and depression similar to what they would likely receive from social workers in their pediatric medical clinic. Because emotional difficulties such as the experience of depressive symptoms have been linked with the severity and course of IBD symptoms, this information may enable parents to better help their child cope with his/her physical illness. In addition, participants in both groups may experience reduced depression and improved quality of life.

It is predicted that those in the CBT group will benefit by learning effective strategies for coping with IBD and depression, enhancing their social skills, and improving family communication skills while those in the supportive therapy group will benefit by receiving social support and useful information. The proposed study will help determine which psychosocial approach is of greater benefit for depressed youth with IBD and provide a model for integrating behavioral treatment to decrease both emotional and IBD-related suffering into the comprehensive medical care for IBD in the pediatric population.

Aim 1(primary) Are there differences between the two types of therapy in terms of improving depression.

Aim 2 (secondary) Are there differences between the two types of therapy in terms of improving IBD activity, quality of life, and medication adherence? Aim 3) (secondary) Are there differences between the two types of therapy in terms of improving sleep and pain? Aim 4) (exploratory) Are anxiety, steroid use, and gender moderators of treatment outcome.

Other known NCT identifiers

• NCT00596869

Recruitment information / eligibility

• Status: Completed
• Enrollment: 76
• Est. completion date: December 2019
• Est. primary completion date: December 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 9 Years to 17 Years

Eligibility

Inclusion Criteria:

Step 1:

• ages 9 to 17 inclusive

• capable of completing CDI

• meeting diagnostic criteria for CD (the date of diagnosis = date of the first diagnostic test confirming CD)

• absence of mental retardation by history

• having at least one appointment at the GI clinic (this will include patients followed in these clinics as well as those seeking consultation)

Step 2:

• CDI or CDI-P greater than or equal to 10 at Step 1.

• ages between 9-17 inclusive

• having CD

Exclusion Criteria:

• history or current episode of bipolar disorder, eating disorder, or psychotic disorder by DSM-IV criteria

• mental retardation by history

• antidepressant medications within one month of assessment

• suicidality with plan or of severity requiring immediate psychiatric hospitalization or significant act involving intentional self-harm (e.g., cutting or overdose, resulting in medical attention)

• unacceptable risk for dangerousness to others as indicated by homicidal (or other violent) ideation, intent or plan or action, or use of illegal weapons

• current pregnancy by history

• substance abuse by history within one month of enrollment other than nicotine dependence

• current treatment with CBT or failure of previous CBT trial for depression judged adequate by at least 12 treatment sessions over a period of less than 1 year conducted by an appropriately trained mental health provider using a manual

• if currently receiving other psychotherapy modalities willingness to suspend treatment for 12-week acute treatment phase of study

Related Conditions & MeSH terms

• Depression
• Inflammatory Bowel Disease
• Inflammatory Bowel Diseases
• Intestinal Diseases

Intervention

Behavioral:
• Cognitive Behavioral Therapy
Participants will receive 12 weeks of CBT designed for youth with IBD. During sessions, participants will learn new ways of thinking (e.g., reconstruction of personal physical illness narratives, coping strategies, social skills) and behaving (e.g., positive activities, family communication, sleep hygiene, relaxation) to improve emotional and physical outcomes. Parent sessions will be provided at the beginning, middle, and end of the treatment to improve family understanding and communication about the physical illness and about risks of developing depression. There will also be 6-month booster sessions during follow-up. Other Name: Primary and secondary coping enhancement training (PASCET)
• Supportive Non-directive Therapy (SNDT)
SNDT is a 12-week non-directive therapeutic intervention. Participants will receive social support and quality information about the warning signs and risk factors for depression. Parent sessions will be provided at the beginning, middle, and end of the treatment to improve family understanding and communication about the physical illness and about risks of developing depression. There will also be 6-month booster sessions during follow-up.

Locations

Country	Name	City	State
United States	Children's Hospital-Boston	Boston	Massachusetts
United States	Children's Hospital of Pittsburgh	Pittsburgh	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Pediatric Crohns Disease Index	Clinician rated instrument of IBD activity which includes symptoms and objective lab results.	Month 0, Month 3
Other	Pediatric Ulcerative Colitis Index	Clinician rated instrument of gastrointestinal symptoms.	Month 0, Month 3
Other	IMPACT 3	Health-related quality life measure. Self report.	Month 0, Month 3
Primary	Change from baseline in CDRS at 3 months	Change in Child Depression Rating Scale (CDRS) score from month 0 assessment to three month assessment.	Month 0, Month 3
Secondary	Change from baseline in KSADS diagnosis at 3 months	Remission of depressive episode as measured by Kiddie Schedule for Affective Disorders and Schizophrenia (KSADS) from month 0 assessment to 3 month assessment.	Month 0, Month 3